DCSYX | FTSDX | DCSYX / FTSDX | |
Total Expense Ratio | 0.67 | 1.17 | 57% |
Annual Report Gross Expense Ratio | 0.67 | 1.17 | 57% |
Fund Existence | 29 years | 22 years | - |
Gain YTD | 9.798 | 6.999 | 140% |
Front Load | N/A | 4% | - |
Min. Initial Investment | 5000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 271M | 5.21B | 5% |
Annual Yield % from dividends | 1.78 | 1.95 | 91% |
Returns for 1 year | 7.88 | 8.24 | 96% |
Returns for 3 years | 46.62 | 20.05 | 232% |
Returns for 5 years | 79.89 | 32.79 | 244% |
Returns for 10 years | 102.71 | 43.55 | 236% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PRDMX | 51.55 | 0.54 | +1.06% |
T. Rowe Price Diversified Mid Cap Gr | |||
LMCQX | 33.70 | 0.29 | +0.87% |
Lord Abbett Mid Cap Stock R2 | |||
HLHIX | 27.92 | 0.13 | +0.47% |
Virtus KAR Health Sciences Inst | |||
VDADX | 56.74 | 0.26 | +0.46% |
Vanguard Dividend Appreciation Index Adm | |||
AVDNX | 14.52 | -0.01 | -0.07% |
Avantis® International Equity G |